The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathological outcomes of HER2-positive early breast cancer patients treated with neoadjuvant trastuzumab or dual anti-HER2 therapy and carboplatin with docetaxel: A Maria Sklodowska-Curie National Research Institute of Oncology experience.
 
Agnieszka I. Jagiello-Gruszfeld
Honoraria - Amgen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis
Research Funding - Celon Pharma; Roche
 
Izabela Lemanska
Speakers' Bureau - Roche; Roche
Travel, Accommodations, Expenses - Egis Pharmaceuticals; Egis Pharmaceuticals; Egis Pharmaceuticals
 
Renata Sienkiewicz
Travel, Accommodations, Expenses - Pierre Fabre; Pierre Fabre
 
Ewa Szombara
No Relationships to Disclose
 
Roman Dubianski
No Relationships to Disclose
 
Elzbieta Brewczynska
No Relationships to Disclose
 
Katarzyna Pogoda
Honoraria - Alvogen; Amgen; AstraZeneca; Egis Pharmaceuticals; Novartis; Pfizer; Pierre Fabre; Roche; Teva
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Roche
Research Funding - AstraZeneca; Lilly; Merck; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; Pfizer; Pierre Fabre; Roche
 
Aleksandra Konieczna
No Relationships to Disclose
 
Michal Kunkiel
No Relationships to Disclose
 
Anna Majstrak-Hulewska
No Relationships to Disclose
 
Wojciech P Olszewski
No Relationships to Disclose
 
Anna Niwinska
Consulting or Advisory Role - Novartis
Research Funding - Roche
 
Zbigniew Nowecki
No Relationships to Disclose